Persistent Tissue Kinetics and Redistribution of Nanoparticles, Quantum Dot 705, in Mice: ICP-MS Quantitative Assessment
2007

Study of Quantum Dot 705 in Mice

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Yang Raymond S.H., Chang Louis W., Wu Jui-Pin, Tsai Ming-Hsien, Wang Hsiu-Jen, Kuo Yu-Chun, Yeh Teng-Kuang, Yang Chung Shi, Lin Pinpin

Primary Institution: National Health Research Institutes, Zhunan, Taiwan

Hypothesis

What are the tissue disposition and pharmacokinetics of QD705 in mice?

Conclusion

QD705 has a very long half-life in the body, potentially weeks or even months, and its health consequences deserve serious consideration.

Supporting Evidence

  • QD705 was found to persist in the spleen, liver, and kidneys for 28 days after injection.
  • The plasma half-life of QD705 was determined to be 18.5 hours.
  • High levels of QD705 were detected in the liver, spleen, and kidneys throughout the study.
  • Mass balance studies showed nearly 100% recovery of the injected dose at both 1 and 28 days.
  • Fluorescence microscopy revealed QD705 localization in vascular-rich areas of the liver, spleen, and kidneys.

Takeaway

Scientists studied a special type of tiny particles called quantum dots in mice to see how long they stay in the body and where they go. They found that these particles can stay in important organs for a very long time.

Methodology

Mice were injected with QD705 and monitored for 28 days, measuring blood and tissue levels using ICP-MS and fluorescence microscopy.

Limitations

The study primarily focused on a single type of quantum dot and its effects in a specific animal model.

Participant Demographics

6-week-old male ICR mice, weighing between 32.9 and 38.7 g.

Digital Object Identifier (DOI)

10.1289/ehp.10290

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication